by Mark Curtis | Oct 3, 2013
. I have recently joined the business development group at CCRM, as an analyst, and believe it would be useful to start compiling some recaps on clinical developments in the regenerative medicine (RM) and cell therapy industries to complement the other science-related...
by Stacey Johnson | Sep 20, 2013
. You have no doubt heard and read a lot about 3D printing. Biomaterials scientist and blogger Patrick Blit has written about it here in the context of a 3D printed tracheal splint. It is an increasingly popular method for creating human tissues and has evolved to...
by Paul Krzyzanowski | Sep 10, 2013
. Earlier this summer I had the fortunate opportunity to speak with Dr. Michael West, of BioTime, and pick his brain on various aspects of the stem cell industry, what it’s faced, and where it might go. It was a perfect follow up to my post in March that explored...
by Nick Dragojlovic | Jul 23, 2013
Would you use/support crowdfunding for research? Take the survey at the end of this post. . Biomedical research is expensive, and existing sources of funding often fall short. Profitable business models for the development of cell-based therapies are still being...
by David Brindley | Jul 9, 2013
. At the close of ISSCR2013, I left Boston bathed in an ochre sunset, and settled on a plane to reflect on what my most unexpected learning had been. My plane was bound not for home (London), but for Istanbul, where the TERMIS meeting was about to begin. As far as I’m...
by Paul Krzyzanowski | Jul 3, 2013
George Daley (File photo) Immediately after last month’s ISSCR meeting, George Daley travelled to the University of Toronto where he had been invited to be an external reviewer on a PhD thesis defense. While there, Daley spoke to a packed audience interested in what...
Comments